Protected Carotid-Artery Stenting versus Endarterectomy in High-Risk Patients
Author(s) -
Jay S. Yadav,
Mark H. Wholey,
Richard E. Kuntz,
Pierre Fayad,
Barry T. Katzen,
Gregory Mishkel,
Tanvir Bajwa,
Patrick L. Whitlow,
Neil E. Strickman,
Michael R. Jaff,
Jeffrey J. Popma,
David B. Snead,
Donald E. Cutlip,
Brian G. Firth,
Kenneth Ouriel
Publication year - 2004
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa040127
Subject(s) - medicine , carotid endarterectomy , carotid stenting , stroke (engine) , endarterectomy , stenosis , asymptomatic , cardiology , stent , revascularization , surgery , myocardial infarction , cumulative incidence , clinical endpoint , randomized controlled trial , cohort , mechanical engineering , engineering
Carotid endarterectomy is more effective than medical management in the prevention of stroke in patients with severe symptomatic or asymptomatic atherosclerotic carotid-artery stenosis. Stenting with the use of an emboli-protection device is a less invasive revascularization strategy than endarterectomy in carotid-artery disease.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom